Metabolomics studies on mouse liver samples on a Western diet

Metabolomics studies on mouse liver samples on a Western diet
ST003253 · Metabolomics Workbench

TL;DR — A 357.1 KB metabolomics / lipidomics deposit (ST003253, 3 file(s), liver) in the MASLD / NAFLD / NASH data lake. under-mined portal (Metabolomics Workbench); modality=metabolomics.


0. Summary

Biological premise.

The following premise is sourced from the repository record (not fabricated).

Presently, dietary patterns have undergone significant shifts, and understanding the intricate interplay between diet, particularly high fat and high sucrose diets, the gut microbiome, and cardiometabolic health has become paramount. These dietary patterns have been consistently associated with heightened cardiometabolic risk factors including obesity, insulin resistance, dyslipidemia, and hypertension. High-fat diets, in particular, contribute to increased adiposity and ectopic fat deposition, exacerbating systemic inflammation and oxidative stress, thereby promoting the development of metabolic dysfunction. Similarly, high sucrose diets have been implicated in the dysregulation of glucose homeostasis, leading to insulin resistance and hyperglycemia, key hallmarks of cardiometabolic diseases such as type 2 diabetes mellitus. Amidst this, the exploration of multi-omic profiles alongside the gut microbial landscape has emerged as a pivotal avenue for unraveling the complexities of cardiometabolic health dynamics affected by the effects of high-fat and high-sucrose diets. The approach of using a multi-omic comparison between organs offers a comprehensive lens through which the intricate molecular signatures underlying the impact of dietary compositions, particularly high fat and high sucrose, on metabolic health, can be examined. Presently, dietary patterns have undergone significant shifts, and understanding the intricate interplay between diet, particularly high fat and high sucrose diets, the gut microbiome, and cardiometabolic health has become paramount. These dietary patterns have been consistently associated with heightened cardiometabolic risk factors including obesity, insulin resistance, dyslipidemia, and hypertension. High-fat diets, in particular, contribute to increased adiposity and ectopic fat deposition, exacerbating systemic inflammation and oxidative stress, thereby promoting the development of metabolic dysfunction. Similarly, high sucrose diets have been implicated in the dysregulation of glucose homeostasis, leading to insulin resistance and hyperglycemia, key hallmarks of cardiometabolic diseases such as type 2 diabetes mellitus. Amidst this, the exploration of multi-omic profiles alongside the gut microbial landscape has emerged as a pivotal avenue for unraveling the complexities of cardiometabolic health dynamics affected by the effects of high-fat and high-sucrose diets. The approach of using a multi-omic comparison between organs offers a comprehensive lens through which the intricate molecular signatures underlying the impact of dietary compositions, particularly high fat and high sucrose, on metabolic health, can be examined. Presently, dietary patterns have undergone significant shifts, and understanding the intricate interplay between diet, particularly high fat and high sucrose diets, the gut microbiome, and cardiometabolic health has become paramount. These dietary patterns have been consistently associated with heightened cardiometabolic risk factors including obesity, insulin resistance, dyslipidemia, and hypertension. High-fat diets, in particular, contribute to increased adiposity and ectopic fat deposition, exacerbating systemic inflammation and oxidative stress, thereby promoting the development of metabolic dysfunction. Similarly, high sucrose diets have been implicated in the dysregulation of glucose homeostasis, leading to insulin resistance and hyperglycemia, key hallmarks of cardiometabolic diseases such as type 2 diabetes mellitus. Amidst this, the exploration of multi-omic profiles alongside the gut microbial landscape has emerged as a pivotal avenue for unraveling the complexities of cardiometabolic health dynamics affected by the effects of high-fat and high-sucrose diets. The approach of using a multi-omic comparison between organs offers a comprehensive lens through which the intricate molecular signatures underlying the impact of dietary compositions, particularly high fat and high sucrose, on metabolic health, can be examined.

Targeted metabolomics was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).to measure polar metabolites in both positive and negative ionization mode on cardiac mice tissue acquired after a 30 week dietary intervention. Targeted metabolomics was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).to measure polar metabolites in both positive and negative ionization mode on cardiac mice tissue acquired after a 30 week dietary intervention. Targeted metabolomics was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS).to measure polar metabolites in both positive and negative ionization mode on cardiac mice tissue acquired after a 30 week dietary intervention.

Every file in this dataset is a metabolomics / lipidomics readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from Metabolomics Workbench.

Assay and processing.

Modality: metabolomics / lipidomics (repository subtype: metabolomics). Tier-1 (must-have) for this modality = feature × sample intensity matrix (MAF/data table) + sample factors; Tier-2 (recommended) = feature annotation (m/z, RT, HMDB/KEGG ids), author DE/pathway tables, QC pools; Tier-3 (optional / raw) = raw spectra (.mzML/.cdf/vendor), peak-picking parameters. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.

Sources.

  • ST003253 — Metabolomics Workbench deposit (under-mined portal (Metabolomics Workbench); modality=metabolomics).
  • PMIDs: none recorded in the index for this deposit.
DiseaseMASLD / NAFLD / NASH
Assay / modalitymetabolomics / lipidomics — metabolomics
Organismsunspecified
RepositoryMetabolomics Workbench — NIH Metabolomics Workbench
AccessionST003253
AccessPublic (open); files mirrored in this dataset's input/ folder.
Number of studies1
Number of files3
Total size357,099 bytes (≈ 357.1 KB)

1. Datasets — sample sources, protocols, experiment design and metadata

Landed sources at a glance.

SourceAccessFiles
Metabolomics Workbenchpublic / OPEN-processed3

The deposit at a glance.

AccessionDescriptionOrganismSamplesScale
ST003253under-mined portal (Metabolomics Workbench); modality=metabolomicsunspecifiedn/a3 files · 357.1 KB

ST003253 — Metabolomics studies on mouse liver samples on a Western diet

Metabolomics Workbench record · 3 files · 357.1 KB

  • Sample source. unspecified material; MASLD/NAFLD/NASH context (under-mined portal (Metabolomics Workbench); modality=metabolomics).

  • Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.

  • Experiment design. Repository subtype: metabolomics; disease context MASLD/NAFLD/NASH.

  • Metadata available. See the annotated file table below; per-sample metadata ships in the ISA-Tab / SDRF / metadata file(s) where present.

  • Files (annotated).

    FileWhat it is
    ST003253_mwtab.txtMetabolomics Workbench mwTab — study design, sample factors, and named-metabolite × sample data table (1,035 data rows × 1 cols)
    ST003253_data.txtNamed-metabolite × sample data table (feature intensities) (10,684 data rows × 2 cols)
    ST003253_named_metabolites.txtNamed-metabolite reference list (identified features) (29 data rows × 2 cols)
  • How this experiment became a dataset. ST003253 resolved via the Metabolomics Workbench record API → 3 open file(s) fetched into this dataset's input/ folder → sizes verified on disk (357,099 bytes (≈ 357.1 KB)).

  • Completeness (metabolomics / lipidomics). Present: feature/intensity table (Tier-1); metabolite annotation (Tier-2). Not detected among landed files: sample factors (Tier-1). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)


2. Analyses this atlas supports

  • Differential-abundance / pathway analysis. Start from ST003253_data.txt (feature × sample intensities) to run group contrasts and metabolite-set enrichment.
  • Cross-cohort MASLD integration. Combine this deposit (ST003253) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.

Reproduce. All files are in this dataset's input/ folder; the source of record is ST003253 (https://www.metabolomicsworkbench.org/rest/study/study_id/ST003253/mwtab/txt). Re-fetch with the MASLD crawler (masld_download_pass.py --only ST003253); sizes are verified on disk and recorded in this dataset's metadata.json.


Citation

Metabolomics studies on mouse liver samples on a Western diet. Metabolomics Workbench accession ST003253. https://www.metabolomicsworkbench.org/rest/study/study_id/ST003253/mwtab/txt

About this dataset

This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.